Year 2 Drugs List Flashcards

1
Q

Antacids:

Drugs

MOA

Indications

Side effects

A
  • Aluminium hydroxide and magnesium hydroxide
  • Calcium carbonate and magnesium carbonate

MOA: Buffer gastric acid to raise pH

Indications:

  • Dyspepsia/heartburn
  • Acid reflux

Side effects:

  • Nausea
  • Aluminium can cause constipation
  • Magnesium can cause diarrhoea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Antacids and alginates:

Drugs

MOA

Indications

Side effects

A
  • Sodium alginate with sodium bicarbonate

Anionic polysaccharides that form viscous gel upon binding with water which floats on top of stomach contents, reducing reflux symptoms & protecting oesophageal mucosa

Also increases viscosity of stomach contents to reduce acid reflux.

Indications:

  • Gastric reflux/ reflux oesophagitis

Side effects:

  • Abdominal distension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

H2 receptor antagonists:

Drugs

MoA

Indications

Side effects

A
  • Ranitidine
  • Cimetidine

Competitive inhibition of histamine actions at gastric H2 histamine receptors in parietal cells to decrease acid secretion by up to 90%

Indications:

  • Stomach ulcers
  • Reflux oesophagitis

Side effects:

  • Dizziness
  • Cimeditine inhibits many cytochrome P450 enzymes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Proton-pump inhibitors:

Drugs

MOA

Indications

Side effects/interactions

A
  • Lansoprazole
  • Omeprazole

Irreversible inhibition of H+/K+ ATPase pump in gastric parietal cells =decreased basal and stimulated acid secretion:

  • From the circulation, the pro-drug (lipophilic) traverses the parietal cell and enters the canaliculus.
  • In acidic canaliculus, drug is activated and trapped.
  • Drug binds to H+/K+-ATPase, irreversibly inactivating it.
  • For acid secretion to resume, new pump molecules have to be synthesized (2-3 days)

Indications:

  • Stomach and duodenal ulcers
  • GORD and reflux oesophagitis

Side effects:

  • Headache
  • Diarrhoea
  • Warfarin interaction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pancreatic enzymes:

Drugs

MOA

Indication

Side effects

A
  • Pancreatin

Restoration of pancreatic enzymes in deficiency.

Indication:

  • Pancreatic insufficiency:
    • Cystic fibrosis
    • Pancreatitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Bulk laxatives:

Drugs

MOA

Indications

Side effects

A
  • Methylcellulose
  • Isphagula husk

Polysaccharide polymers not broken down by normal process of digestion. Retain water in the GI lumen, softening and increasing faecal bulk and promote increased motility. Act in 1-3 days.

Indications:

  • Constipation and IBS

Side effects:

  • Rare
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What classes of drugs are used to treat disorders of acid secretion?

A
  • Antacids and alginates
  • Histamine H2-receptor antagonists
  • Proton pump inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Faecal Softeners:

Drugs

MOA

Indications

Side effects

A
  • Docusate
  • Arachis oil

Stimulates water & electrolyte secretion into intestinal lumen; lower surface tension at oil-water interface allowing water and fat to enter stool cause it to soften. Act 3-5 days

Indications:

  • Constipation
  • Fissures
  • Piles

Side effects:

  • None noted
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Osmotic laxatives:

Drugs

A

Macrogol

​Lactulose

Magnesium sulphate and magnesium hydroxide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Lactulose

MOA

Indications

Side effects/interactions

A

Lactulose (osmotic laxative)

Semi-synthetic disaccharide of fructose and galactose- mimicks undigested lactose

Colonic bacteria convert it to its two component monosaccharides which are poorly absorbed. Fermentation yields lactic acid and acetic acid which function as osmotic laxatives.

Acts within 1-3 days

Indications:

  • Chronic constipation
  • Hepatic encephalopathy
  • Negating the constipating effects of opioids.

Side effects/interactions:

  • Stomach cramps
  • Interacts with antiepileptics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Macrogol

MOA

Indications

Side effects

A

Macrogol (osmotic laxative)

Inert polymers of ethylene glycol. Sequester fluid in the bowel

Uses:

  • Treatment of faecal impaction in children
  • Long-term management of chronic constipation

Side effects/interactions:

  • Stomach cramps
  • Interaction with anti-epileptics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Magnesium sulphate and magnesium hydroxide

MOA

Indications

Side effects/interactions

A

Magnesium sulphate and magnesium hydroxide (osmotic laxatives)

Potent, rapid action (1-2 Bowel prep prior to procedure)

Indications:

  • Bowel prep prior to procedure

Side effects

  • Stomach cramps
  • Interacts with antiepileptics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Stimulant laxatives

Drugs

MOA

Indications

Side effects

A

Bisacodyl

Stimulates rectal mucosa, resulting in mass movements and defaecation in 15-30 minutes Only short courses should be used

Indications:

  • Constipation
  • Opioid related constipation

Side effects:

  • Nausea

Senna

Passes unchanged into colon, where bacterial action releases free anthracene derivatives. Anthracene derivatives are absorbed and have a direct on myenteric plexus to increase intestinal motility (stronger muscle contractions)

Indications:

  • Constipation

Side effects:

  • Nausea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which 4 classes of drugs are purgatives?

A
  • Bulk laxatives
  • Osmotic laxatives
  • Faecal softeners
  • Stimulant purgatives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Opioid anti-motility agents

Drugs

MOA

Side effects

Indications

A
  • Loperamide
  • Codeine

Agonist for μ-opioid receptors in myenteric plexus; increases tone and rhythmic (haustral) contractions of the colon but diminishes propulsive activity. Blocks intestinal muscarinic receptors.

Indications:

  • Diarrhoea (acute, uncomplicated, used in adults)

Side effects:

  • Constipation
  • Abdo cramps
  • Dizziness
  • Paralytic ileus can occur
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Loop diuretics

Drugs

MOA

Indications

Side effects/interactions

A
  • Furosemide
  1. Inhibits Na+/K+/2Cl- transporter (competes with Cl- binding) reducing NaCl reabsorption in the thick ascending LoH therefore decreased water absorption.
  2. Causes decreased osmotic concentration in the medulla therefore decreased ADH mediated H20 absorption.
  3. Increased delivery of NaCl to the DCT causes increased Na+ uptake by principal cells, causing loss of K+ and H+.
  4. Reduce calcium and magnesium absorption

Bind to plasma proteins, not filtered, but secreted directly into PCT so effective in renal impairment.

Indications:

  • Peripheral oedema
  • Acute pulmonary oedema
  • Resistant HTN
  • Left ventricular heart failure

Side effects/interactions:

  • Nausea
  • Hypotension
  • Dizziness
  • Hypovolaemia
  • Hyponatraemia/hypokalaemia
  • Ototoxicity (high doses)
  • Interacts with NSAIDs and ACE-inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Thiazide and thiazide-like diuretics

Drugs

MOA

Indications

Side effects/interactions

A
  • Indapamide
  • Bendroflumethiazide
  • Chlortalidone
  • Hydrochlorothiazide

Inhibits Na+/Cl- co-transporter in early DCT (compete with Cl- binding) so increasing Na+ in lumen therefore water. Decreased sodium and chloride reabsorption.

Vasodilate by potassium channel activation

Filtered and secreted so not useful in renal impairment

Indications:

  • Hypertension
  • Peripheral oedema (HF)

Side effects/interactions:

  • Weak/moderate diuresis,
  • Hyponatraemia/hypokalaemia
  • Increased plasma uric acid (gout)
  • Erectile dysfunction
  • Hyperglycaemia
  • Raised cholesterol
  • Interacts with digoxin and NSAIDs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Potassium sparing diuretics: aldosterone antagonists

Drugs

MOA

Indications

Side effects/interactions

A
  • Spironolactone
  • Eplenerone

Aldosterone antagonist binds to mineralocorticoid receptor in the late DCT/cortical collecting tubule. Prevents synthesis of ENaC and Na+/K+ATPase activation therefore reduced K+ secretion into the lumen (K+ retained) and reduced Na+ reabsorption and accompanying water.

Indications:

  • Oedema
  • Congestive heart failure
  • Ascites caused by liver cirrhosis
  • Hyperaldosteronism (Conn’s syndrome)
  • Resistant HTN, in combination with loop/thiazide diuretics to prevent K+ loss.

Side effects/interactions:

  • Interacts with NSAIDs and ACE-inhibitors
  • Hyperkalaemia
  • Gynaecomastia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Potassium sparing diuretics: ENaC antagonists

Drugs

MOA

Indications

Side effects/interactions

A
  • Amiloride

Blockade of sodium reabsorption via ENaC channel (competes for Na binding site) therefore decreases luminal permeability to Na+. Causes reduced K+ secretion into the lumen, therefore K+ retained.

Used in combination to prevent K+ loss from use of loop/thiazide diuretics

Indications:

  • Oedema
  • Congestive HF

Side Effects:

  • Hyperkalaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Osmotic diuretics

Drugs

MOA

Indications

Side effects/interactions

A
  • Mannitol

Increases osmolality of glomerular filtrate preventing water reabsorption in the PCT and descending LoH

Indications:

  • Raised intraocular pressure
  • Cerebral oedema

Side effects:

  • Hypotension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Why do loop and thiazide diuretics cause hypokalaemia?

Why may alkalosis also occur alongside this?

A

They increase delivery of NaCl to the distal nephron and decrease blood volume.

This increases K+ secretion by:

  • Increasing tubular flow rate (K+ washes away creating high concentration gradient)
  • Increases activity of Na+/K+ATPase via increased Na+ therefore more K+ is secreted out of the cells
  • Activation of RAAS from decreased blood volume = increased aldosterone therefore more Na+ reabsorption in kidneys = more K+ secreted.

May also cause alkalosis as it can stimulate intercalated cells to secrete H+ so more acid is lost in urine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Carbonic anhydrase inhibitors

Drugs

MOA

Indications

Side effects/interactions

A
  • Acetazolamide

Reduces aqueous humour volume by preventing renal absorption of bicarbonate:

Inhibit carbonic anhydrase in the PCT, preventing it from converting carbonic acid to water and CO2, therefore blocking the absorption of HCO3- and the accompanying sodium and water.

Indications:

  • Raised intra ocular pressure: open and closed angle glaucoma

Side effects/interactions:

  • Paraesthesias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

ACE-Inhibitors

Drugs

MOA

Indications

Side effects/interactions

A
  • Ramipril
  • Captopril

Inhibits angiotensin converting enzyme, preventing it from converting angiotensin I to angiotensin II. This prevents it from inducing contraction in vascular smooth muscle and increasing BP.

Indications:

  • Hypertension
  • T1 Diabetic nephropathy
  • Congestive heart failure
  • Post MI
  • Secondary stroke prevention

Side effects/interactions:

  • Cough (through inhibited breakdown of bradykinin in the lungs)
  • Hyperkalaemia (potassium retained by blocking RAAS)
  • Hypotension
  • Angioedema
  • Decreased GFR as angiotensin normally constricts efferent arterioles
  • Caution in renal artery stenosis- can precipitate kidney failure
  • Interacts with NSAIDs and Lithium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Angiotensin II receptor blockers

Drugs

MoA

Indications

Side effects/interactions

A
  • Losartan
  • Valsartan

Blockade of cell signalling induced by angiotensin II. Binds to type 1 angiotensin II receptors preventing the direct vasoconstriction effects of ATII and its action in the RAAS system (release of aldosterone)

Indications:

  • Hypertension
  • T2 diabetic nephropathy
  • CHF
  • LV hypertrophy
  • ACE-i intolerance

Side effects/interactions:

  • Hypotension
  • Fatigue
  • Hyperkalaemia
  • Myalgia
  • Raised CPK
  • Diuretics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Neprilysin inhibitors Drugs MoA Indications Side effects/interactions
* **Sacubitril (incombinatin with ARB)** Inhibits the breakdown of natriuretic peptide Indications: * Heart failure with reduced ejection fraction Side effects/interactions: * Hypotension * Hypoglycaemia
26
Beta adrenergic receptor antagonists (B-blockers) Drugs MoA Indications Side effects/interactions
* **Bisoprolol** * **Atenolol (B1 cardioselective)** * **Propranolol (B1 and B2)** Competitive inhibitors of adrenaline and noradrenaline at beta-adrenergic receptors, inhibit sympathetic stimulation of heart muscle.(B1 antagonists selective for cardiomyocytes and contractility) by inhibiting cAMP cascade (PKA etc) which in cardiomyocytes drives contraction (opposite to bronchiolar smooth muscle) * Negative inotropes and chronotropes. * Reduce workload of the heart relieving oxygen demand. (reduced heart rate = reduced cardiomyocyte contractility) Indications: * Hypertension * Stable angina Side effects/interactions: * Bradycardia * Bronchospasm * Dizziness (hypotension) * Constipation * Interacts with NSAIDs and digoxin **Contraindicated in asthmatic patients**
27
Alpha adrenergic receptor blockers (A-blockers) Drugs MoA Indications Side effects/interactions
* **Doxazosin** Selective alpha1 adrenergic receptor blocker in the bladder neck, urethra and prostate. Prevents sympathetic neurons from initiating smooth muscle contraction, causing relaxation which allows urinary flow. Vasodilator, decreases total peripheral resistance by inhibiting the postsynaptic alpha-1 receptors on vascular smooth muscle. Indications: * Hypertension * BPH * Urinary retention Side effects/interactions: * Dizziness * Headache * Nausea * Dry mouth * Constipation * Anxiety * Back pain * Coughing * Dyspnoea * Fatigue * Myalgia * Paraesthesia * Vertigo * Not to be given with hypotensive drugs
28
Calcium channel blockers Drugs MoA Indications Side effects/interactions
* **Amlodipine** * **Nifedipine** * **Diltiazem** * **Verapamil** Prevent opening of L-type voltage-gated calcium channels reducing influx of Ca2+ into cells. Reduced intracellular calcium has vasodilator effect on resistance vessels = reduced afterload. Causes dilation of coronary arteries increasing blood flow. Do not act on veins. Indications: * Hypertension * Stable angina Side effects/interactions: * Oedema * Ankle swelling * Palpitations * Not to be given with beta blockers or digoxin
29
Nitrates Drugs MoA Indications Side effects/interactions
* **Glyceryl trinitrate** * **Isosorbide mononitrate** Metabolised to release NO which diffuses into cell and stimulates soluble guanylate cyclase. Increases cGMP in vascular smooth muscle cells: * Drives dephosphorylation of myosin light chains via activation of MLC phosphatase. * Inhibits influx of Ca2+ into smooth muscle cytoplasm causing relaxation. Works on vascular smooth muscle of arteries and veins: * Venodilation: reduces cardiac preload (capacitance) * Arteriodilation: coronary artery vasodilation increases blood flow to myocardium * Moderate arteriolar dilation: reduces cardiac afterload Indications: * Acute angina pectoris * Heart failure Side effects/interactions: * Hypotension * Headache * Not to be given with antihypertensives
30
Sympathomimetics Drugs MoA Indications Side effects/interactions
* **Adrenaline (alpha and beta)** * **Noradrenaline (alpha)** * **Dobutamine (beta)** Adrenergic stimulation increases inotropy. Adrenaline: Binds and stimulates cardiomyocyte B1-adrenergic receptors. Used in cardiac arrest to drive cardiac muscle contraction and restore heart function. Positive inotrope and chronotrope. Indications: * Cardiac arrest * Cardiogenic shock Side effects/indications: * Arrhythmia
31
Anti-platelet drugs Drugs MoA Indications Side effects/interactions
* **Aspirin** Blocks the enzyme action of platelet COX enzyme which is required for the synthesis of thromboxane A2 (TXA2). Reduced TXA2 synthesis results in inhibition of platelet activation and thrombus formation. * **Clopidogrel** ADP receptor blocker: binds to and block the function of ADP receptors on platelet surfaces, inhibiting platelet activation and subsequent thrombus formation. Indications: * Primary and secondary relief for CVD * Anticoagulant prophylaxis Side effects/interactions: * Gastrointestinal irritation and bleeding * Not to be given with anticoagulants
32
Anticoagulants: coumarin Drugs MoA Indications Side effects/interactions
* **Warfarin** Inhibition of epoxide reductase which results in inhibition of vitamin K pathway and vitamin K-dependent coagulation factors (VII, IX, X and prothrombin/FII) (1972) Indications: * Prophylaxis and treatment of VTE * Prophylaxis of stroke from AF Side effects/interactions * Abnormal bleeding * Drug interactions: NSAIDs, diuretics
33
Anticoagulants: direct thrombin inhibitors Drugs MoA Indications
* **Dabigatran** Competitive, reversible direct inhibition of thrombin. Indications: * Prophylaxis of VTE post surgery
34
Anticoagulants: FXa inhibitors Drugs MoA Indications Side effects/interactions
* **Apixaban** * **Edoxaban** * **Rivaroxaban** Inhibition of factor Xa in the coagulation cascade Indications: * Prophylaxis of stroke from AF * VTE Side effects/interactions: * Abnormal bleeding
35
Anticoagulants: heparins Drugs MoA Indications Side effects/interactions
* **Dalteparin (LMWH)** * **Tinzaparin (LMWH)** * **Enoxaparin (LMWH)** * **Unfractionated heparins** Inactivation of thrombin and factor Xa by reversibly binding to and increasing activation of anti-thrombin III. Indications: * Prophylaxis of VTE and P.E * Treatment of existing clots (higher dose) Side effects/interactions: * Abnormal bleeding
36
Thrombolytics/fibrinolytics Drugs MoA Indications Side effects/interactions
* **Alteplase** * **Urokinase** * **Streptokinase** Activates plasminogen to plasmin for proteolytic breakdown of fibrin and fibrinogen to restore blood flow Indications: * Myocardial infarction * Ischaemic stroke Side effects: * Arrhythmias * Bleeding * Streptokinase can only be used once as an immune response is generated, memory B cells produce anti-streptokinase ABs.
37
HMG-CoA reductase inhibitors Drugs MoA Indications Side effects/interactions
* **Simvastatin** * **Atorvastatin** Inhibiton of malevolate pathway needed for cholesterol synthesis. Inhibit HMG-CoA Reductase (HMGCR) enzyme which reduces circulating cholesterol by: * Reducing intrinsic production of cholesterol * Promoting uptake of excess cholesterol by liver. Indications: * Treatment of HF without affecting BP * Hypercholesterolaemia * Risk of CVD and stroke Side effects/interactions: * Myalgia * Interacts with verapamil and macrolides
38
Class I antiarrhythmics: Sodium Channel Blockers Drugs MoA Indications Side effects/interactions
Mnemonic: 1a antiarrhythmic Does - disopyramide Quiet - quinidine 1 But Lets -Lidocaine 1 Calm Fluttery - Flecainide Pulses- Propafenone Class 1a: * **Disopyramide** * **Quinidine** Class 1b: * **Lidocaine** Class 1c: * **Flecainide** * **Propafenone** Voltage-sensitive sodium channel blockade. Prolongs QT interval and increases QRS duration. Indications: * Class 1a: Ventricular and supraventricular arrhythmias * Class 1b: CPR (given IV) * Class 1c: Paroxysmal atrial fibrillation and ventricular ectopic beats “pill in pocket” Side effects/interactions: * Oedema
39
Class II anti-arrythmics: beta blockers Drugs MoA Indications Side effects/interactions
* **Atenolol** * **Bisoprolol** * **Metoprolol** Beta-adrenergic receptor blockade reducing adrenergic effects on inotropy and chronotropy. Indications: * Prophylaxis of paroxysmal atrial tachycardia or fibrillation Side effects/interactions: * Hypotension * Bradycardia * Bronchospasm * Not to be given with NSAIDs or digoxin
40
Class III anti-arrhythmics: potassium channel blockers Drugs MoA Indications Side effects/interactions
* **Amiodarone** * **Dronedarone** * **Sotalol** (also has some beta blocker activity) Potassium channel blockade, also evidence of beta blocker and calcium channel blocker properties – prolong QT interval. Indications: * Supraventricular, nodal and ventricular tachyarrhythmias, atrial fibrillation * CPR (given IV) Side effects/interactions: * Nausea * Vomiting
41
Class IV antiarrhythmics: calcium channel blockers Drugs MoA Indications Side effects/interactions
* **Verapamil** * **Diltiazem** Cardiac calcium channel blockade- reduction of action potential and cardiac output. Indications: * Supraventricular tachycardia (esp paroxysmal SVT) Side effects/interactions: * Constipation (diltiazem) * Hypotension (verapamil)
42
Cardiac glycosides Drugs MoA Indications Side effects/indications
* **Digoxin** Reduces contractility of AV node. Indications: * Atrial fibrillation * Congestive heart failure Side effects/interactions: * Fatigue * Nausea
43
Adenosine MoA Indications Side effects/interactions
* **Adenosine** Activates adenosine type 2 receptors - coupled to Gs protein --\> stimulates AC --\> increase in CAMP --\> protein kinase activation --\> KATP activation --\> which cause hyperpolarisation. Slows conduction through AV node. (plus smooth muscle relaxation --\> increase in coronary bloody flow). Indications: * Supraventricular tachycardia Side effects/interactions: * Nausea * Contraindicated in obstructive airway disease
44
Anti muscarinic (emergency) Drugs MoA Indications Side effects/interactions
* **Atropine** Blockade of vagal (parasympathetic) muscarinic acetylcholine receptors in the SA and AV nodes. Indications: * Bradycardia (emergency) Side effects/interactions: * Urinary retention
45
Magnesium sulfate MoA Indications Side effects/interactions
* **IV Mg sulfate** Unclear – possible alteration of Na+, K+ and Ca2+ ion balance via ion channels and transporters. Indications: * Emergency arrhythmia * Emergency asthma Side effects/interactions: * Electrolyte irregularities
46
Beta2 adrenergic agonists Drugs MoA Indications Side effects/interactions
* **Salbutamol** (short acting) * **Terbutaline** (short acting) * **Salmeterol** (long acting) * **Formoterol** (long acting) Cellular target: Bronchiolar smooth muscle cells Molecular target: Stimulation of B2-adrenergic receptors * Activation of B2AR activates G-protein * Increases activation of adenylate cyclase * Adenylate cyclase converts ATP to cAMP * Increased cAMP activates protein kinase A which: * Drives Ca2+ into intracellular storage vesicles away from cytoplasm. * Reduces activity of myosin light chain kinase = reduced muscle contraction * Dephosphorylation of myosin light chain = reduced muscle contraction * Reduced cytoplasmic Ca2+ levels reduce smooth muscle contraction resulting in bronchodilation. Indications: * Asthma * Reversible airway obstruction Side effects/interactions: * Tachycardia * Tremor * Cardiac arrhythmias * Interacts with diuretics
47
Anti-cholinergics Drugs MoA Indications Side effects/interactions
* **Ipratropium** (short acting) * **Tiotropium** (long acting) Blocks M3 muscarinic acetylcholine receptors preventing stimulating effects of ACh: * Inhibits activation of G-protein therefore inhibits activation of phospholipase C enzyme (PLC) * PLC therefore cannot release calcium from intracellular stores * Cytoplasmic Ca2+ levels do not rise therefore bronchiolar smooth muscle contraction does not increase (inhibits bronchoconstriction) * =Bronchiolar relaxation Indications: * Acute asthma * Bronchospasm in COPD Side effects/interactions: * Dry mouth * Constipation
48
Methylxanthines Drugs MoA Indications Side effects/interactions
* **Aminophylline** * **Theophylline** Inhibit phosphodiesterase enzymes (PDE) preventing it from inhibiting CAMP. CAMP levels maintained therefore protein kinase A enzyme activated which stores intracellular Ca2+ into storage vesicles. Reduced cytoplasmic Ca2+ results in less smooth muscle contraction so less bronchoconstriction Indications: * Acute asthma * Reversible airways obstruction Side effects/interactions: * Headache * Nausea * Cardiac arrhythmias * Seizures * Interacts with antidepressants and salbutamol
49
Glucocorticoids Drugs MoA Indications Side effects/interactions
* **Beclomethasone** * **Prednisolone** * **Hydrocortisone** * **Fluticasone** Targets immune cells of the lungs: macrophages, T-lymphocytes, eosinophils. Activates glucocorticoid receptors which interact with selected nuclear DNA sequences and influences the expression of genes: * Repression of pro-inflammatory mediators: IL-3, IL-5, Th​2 cytokines * Expression of anti-inflammatory products: secreted leukocyte peptidase inhibitor (SLPI), Lipcortin-1 and upregulation of B2 adrenoceptors. Indications: * Asthma * Allergic rhinitis Side effects/interactions: * Cough * Hyperglycaemia * Muscle wasting * Thinning skin * Osteoporosis * Increased risk of infection * Moon face (facial swelling) * Interacts with aspirin
50
Leukotriene antagonists Drugs MoA Indications Side effects/interactions
* **Motekulast** * **Zafirlukast** Blockade of leukotriene receptors. Leukotrienes released from mast cell upon activation, normally binds to CysLT1 leukotriene receptor to: * Stimulate bronchiolar smooth muscle constriction * Bind to and recruit immune cells such as eosinophils by guiding eosinophil chemotaxis. Leukotriene receptor antagonists block CysLT1 receptors on smooth muscle and eosinophils blocking the above effects. Indications: * Asthma * Allergic rhinitis * (used as a preventor) Side effects/interactions: * Abdominal pain * Interacts with phenobarbital
51
Mucolytic drugs MoA Indications Side effects/interactions
* **Dornase alfa** Synthetic DNAse 1 – breakdown Cystic fibrosis of extracellular DNA to reduce sputum viscosity. Indications: * Cystic fibrosis
52
Synthetic Dopamine Agonists Drugs MoA Indications Side effects/interactions
* **Pramipexole** * **Ropinirole** * **Rotigotine** Synthetic dopamine, act on dopamine receptors (primarily D2) to replace lost dopamine Less overall improvement than levodopa, more psychiatric side effects. Indications: * Parkinson's disease * Esp younger patients to delay the need for levodopa * First line for initial treatment * Can be used with levodopa in later stages Side effects/interactions: * Psychiatric symptoms (due to action on mesocortical and mesolimbic pathways) * Confusion, agitation * Nausea and vomiting * Sudden onset sleep/ drowsiness * On-off effects * Hypotension * Tachycardia * Interacts with MAOIs
53
Levodopa MoA Indications Side effects/interactions
Dopamine precursor: crosses blood brain barrier and is metabolised into dopamine to replace that lost. Works on dopamine receptors to restore activity in the nigrostriatal pathway. Indications: * Parkinson's disease (use as late as possible) Side effects/interactions: * Psychiatric symptoms (due to action on mesocortical and mesolimbic pathways) * Confusion, agitation * Nausea and vomiting * Sudden onset sleep/ drowsiness * On-off effects * Hypotension * Interacts with MAOIs * Tachycardia
54
Monoamineoxidase-B (MAOI-B) inhibitors Drugs MoA Indications Side effects/interactions
* **Selegiline** * **Rasagiline** Inhibition of levodopa breakdown in the CNS by monoamineoxidase-B meaning more is available to be converted into dopamine. Indications: * Parkinson's disease * Use alongside levodopa
55
Dopa-decarboxylase inhibitors Drugs MoA Indications
* **Carbidopa** * **Benserazide** Prevents the breakdown of levodopa in the periphery by dopa-decarboxylase enzyme allowing more to cross the blood brain barrier and be converted into dopamine. Indications: * Parkinson's disease * Use in conjunction with levodopa
56
Catechol-o-methyl transferase (COM-T) inhibitors Drugs MoA Indications Side effects/interactions
* **Entacapone** * **Tolcapone** Prevents breakdown of levodopa in the CNS by Catechol-O-methyltransferase (COM-T) so more is available to be converted to dopamine. Indications: * Parkinson's disease * Use alongside levodopa Side effects/interactions: * Nausea * Vomiting
57
Anticholinergics Drugs MoA Indications Side effects/interactions
* **Orphenadrine** * **Procyclidine** * **Trihexphenadyl** Inhibits cholinergic fibres from the striatum to the globus pallidus that moderate GABAergic cells and prevents them from inhibiting the direct pathway and increase effects of the indirect pathway. Indications: * Parkinson's disease (iatrogenic) * Muscle rigidity * Negate the side effects of anti-psychotics Side effects/interactions: * Can reduce the absorption of levodopa * Dry mouth * Constipation
58
Dopamine depleting drugs MoA Indications Side effects/interactions
* **Tetrabenazine** Inhibits VMAT2 (vesicular monoamine transporter) within basal ganglia, preventing transport of dopamine into presynaptic vesicles therefore less released into the synaptic cleft. Indications: * Huntington's chorea Side effects/interactions: * Affects all monoamines: 5-HT and NA * Can cause depression
59
Selective Serotonin Re-uptake Inhibitors (SSRIs) Drugs MoA Indications Side effects/interactions
* **Sertraline** * **Citalopram** * **Fluoxetine** Inhibition of 5-HT reuptake pump in synaptic cleft. Indications: * Depression * Generalised anxiety disorder Side effects/interactions: * Slow onset, can increase depressive symptoms initially * Nausea * Sleep disorders * Sexual dysfunction * Increased bleeding * Serotonin syndrome (increased 5-HT levels)- Emergency * Interacts with NSAIDs and lithium
60
Reversible inhibitors of monoamine oxidase type A (RIMA) Drugs MoA Indications Side effects/interactions
* **Moclobemide** Increases 5-HT and noradrenaline levels by reversibly inhibiting enzymatic breakdown by monoamine oxidase A. Indications: * Depression Side effects/interactions: * Tachycardia * Also affects dopamine levels * DO NOT USE WITH TCAs/SSRIs * Interacts with cheese (contains tyramine) * Postural hypotension * Restlessness * Convulsions * Sleep disorders
61
Tricyclic antidepressants (TCAs) Drugs MoA Indications Side effects/interactions
* **Amitryptiline** * **Nortryptiline** * **Dosulepin** 5 main actions: * Therapeutic effects: * 5HT reuptake inhibitor * Noradrenaline reuptake inhibitor * Side effect causing: * A1 adrenoceptor antagonist * Postural hypotension * H1 receptor antagonist: * Sedation * M1 receptor antagonist * Cardiac dysrhythmia Indications: * Depression Other side effects: * Confusion * Mania
62
Atypical antidepressants: Serotonin Noradrenaline Reuptake Inhibitors Drugs MoA Indications
* **Venlafaxine** Inhibits the reuptake pumps of both 5-HT and noradrenaline Indications: * Depression
63
Atypical antidepressants: Noradrenaline reuptake inhibitors Drugs MoA Indications
* **Raboxetine** Inhibition of the noradrenaline reuptake pump. Indications: * Depression
64
Atypical antidepressants: Melatonin Agonist Drugs MoA Indications
* **Agomelatine** Increases slow wave sleep to prolong sleep duration and reset sleep patterns. Indications: * Depression
65
Atypical antidepressants: Noradrenaline dopamine reuptake inhibitors Drugs MoA Indications
* **Bupropion** Inhibition of the noradrenaline and dopamine reuptake pumps in the synaptic cleft. Indications: * Depression
66
Atypical antidepressants: a2-adrenoceptor antagonist MoA Indications Side Effects/interactions
* **Mirtazipine** Increase neurotransmitter release by inhibiting a2 receptors which normally slow transmitter release. Indications: * Depression Side effects/interactions: * Decreased vascular flow in extremities * Postural hypotension * Fatigue * Bronchoconstriction * Cardiac failure * Bradycardia * Sleep disorders * Impotence
67
First generation antipsychotics Drugs MoA Indications Side effects/interactions
* **Haloperidol** * **Chlorpromazine** Selective dopamine D2 receptor antagonists. Also affect M1, H1, alpha1 receptors. Low efficacy (30% non-responders) Indications: * Schizophrenia * Haloperidol: used for short term treatment of extreme or aggressive behaviour, rapid tranquilisation * Haloperidol: huntington's Side effects/interactions: * Blurred vision * Tremor * Extrapyramidal symptoms (result of altering activity of nigrostriatal pathways): * Dystonias * Akathisia * Parkinsonism * Sedation * Seizures * Hypotension * Hypothermia * Hypersensitivity * Chlorpromazine: agranulocytosis * Tardive dyskinesia from prolonged use (choreiform movements, grimacing, tongue protruding)
68
Second generation (atypical) antipsychotics Drugs MoA Indications Side effects/interactions
* **Olanzapine** Antagonism of D1, D2, D3 and D4 receptors in the brain, 5HT2A, 5HT2C, 5HT3 and 5HT6 receptors, alpha-1 adrenergic receptor, histamine receptor H1 and multiple muscarinic receptors. * **Risperidone** ​5HT2A and Dopamine antagonist * **Quetiapine** Antagonism of dopamine type 2 (D2) and serotonin 2A (5HT2A) receptors * **Clozapine** ​5HT2A and domapine antagonist * **Amisulpride** ​5HT7 and Dopamine (D1 & D2) antagonist (mesolimbic pathway) Indications: * Schizophrenia Side effects/interactions: * Extrapyramidal symptoms * Hypotension
69
Mood stabilisers Drugs MoA Indications Side effects/interactions
* **Lithium carbonate** MOA unclear Indications: * Bipolar disorder Side effects/interactions: * Tremor * Hypothyroidism * Interacts with NSAIDs and ACE-inhibitors
70
Cholinesterase inhibitors Drugs MoA Indications Side effects/interactions
* **Donepezil** * **Galantamine** * **Rivastigmine** Reversible inhibition of acetylcholinesterase Indications: * Dementia (mild to moderate) * Alzheimer's disease Side effects: * Nausea * Vomiting
71
NDMA receptor antagonists Drugs MoA Indications Side effects/interactions
* **Memantine** VD blocker of NDMA receptors Indications: * Dementia (moderate to severe) * Alzheimer's disease Side effects/interactions: * Constipation * Hypertension
72
Anxiolytics: Benzodiazepines Drugs MoA Indications Side effects/interactions
* **Lorazepam** * **Midazolam** * **Diazepam** * **Zolpidem** (benzodiazepine-like) * **Temazepam** GABA PAM (y subunit). Enhanced effects of GABA. Co-agonist (positive allosteric modulators) which bind to the y-subunit of the GABAA receptor to increase action of GABA. Reduces neuronal transmission by increasing chloride entry into the cell leading to hyperpolarisation and decreased likelihood of action potential firing. Indications: * Anxiety and related disorders * Epilepsy * Acute seizures * Temazepam: sedation Side effects/interactions: * Drowsiness * Dependence * Not to be given with sedatives
73
Anxiolytics: Buspirone MoA Indications
5-HT1A partial agonist Indications: * Anxiety and related disorders
74
Non-benzodiazepine hypnotic Drugs MoA Indications
* **Zopiclone** GABA PAM (γ-subunit) Enhanced effects of GABA Indications: * Insomnia
75
Anti-epileptic drugs: calcium channel blockers Drugs MoA Interactions Side effects/interactions
* **Ethosuximide** T-type calcium channel blocker Indications: * Epilepsy: generalised absence seizures first line Side effects/interactions: * Do not use with macrolide antibiotics * Nausea * Blurred vision
76
Anti-epileptic drugs: sodium channel blockers Drugs MoA Indications Side effects/interactions
* **Sodium valproate** * **​**Generalised tonic-clonic seizures (first line) * Generalised abscence seizures (first line) * Generalised myoclonic seizures (first line) * Generalised abscence atypical, generalised tonic and generalised atonic seizures (first line) * **Lamotrigine** * Focal and focal to generalised seizures (first line) * Generalised tonic-clonic seizures (first line) * **Carbamazepine** * ​Focal and focal to generalised seizures (first line) Sodium channel blockers in inactivated state. Indications: * Epilepsy (see above) Side effects/interactions: * Sodium Valproate: Teratogenicity: foetal developmental defects * Cognitive impairment * Visual impairment * Peripheral neuropathy * Gum hyperplasia * Anaemia * Osteomalacia
77
Benzodiazepine antagonist Drugs MoA Indications
* **Flumazenil** Antagonises GABA signalling Indications: * Reversal of benzodiazepine sedation
78
Barbiturates Drugs MoA Indications Side effects/interactions
* **Phenobarbitone** * **Pentobarbitone** * **Primidone** Co-agonist of the GABAA receptor (B subunit) to increase activity. Reduces neuronal transmission by enhancing inhibition Indications: * Epilepsy/acute seizures * Anaesthesia/anxiolytic Side effects/interactions: * Dizziness/fainting * Drowsiness * Withdrawal on termination * Tolerance and dependency * Impaired motor coordination * Sedation * Impaired cognitive function * Retrograde amnesia * Interacts with sedatives and anticoagulants
79
Paracetamol MoA Indications Side effects/interactions
Possible COX inhibitor, MoA unclear. Indications: * Mild-moderate nociceptive pain * Pyrexia Side effects/interactions: * Constipation * Interacts with warfarin
80
NSAIDs Drugs MoA Indications Side effects/interactions
* **Ibuprofen** * **Diclofenac** * **Naproxen** * **Aspirin** Block production of prostaglandins by inhibiting cyclo-oxygenase enzyme: * COX1 : normal cell function * COX2 : inflammation * COX3 : fuck knows Inhibiting COX2 reduces production of inflammatory prostaglandins therefore reduce activation of prostanoid receptor and Na+ channel activation. Reduced Na+ channel activation leads to decreased depolarisation and less pain transmission. Indications: * Mild to moderate pain * Inflammation Side effects/interactions: Inhibiting COX1 inhibits production of PGE1 and PGI2 which have a role in normal physiological processes in platelets, endothelium, kidney, stomach and intestinal function. * Bleeding * Stomach ulcers * Heartburn * Nausea/ vomiting * Diarrhoea * Headache * Tinnitus * Hypertension * Interacts with ACE-inhibitors & diuretics
81
COX2 selective NSAIDs Drugs MoA Indications Side effects/interactions
* **Eterocoxib** * **Celecoxib** COX-2 inhibition, localised prostaglandin blockade Indications: * Pain * Inflammation Side effects/interactions: * Less GI side effects than normal SAIDs * Indigestion * Avoid with NSAIDs and SSRIs
82
Weak opioid analgesics Drugs MoA Indications Side effects/interactions
* **Codeine** * **Dihydrocodeine** Mimic endogenous opioids acting on opioid receptors µ, K, delta and ORL-1. Decrease neuronal transmission by: * Hyperpolarising the cell so it is less likely to fire AP when simulus arrives: * Decreases opening of voltage gated Na+ channels * Increases K+ outflow via KATP and KIR channels * Reduces exocytosis of transmitters * Decreases Ca2+ release from intracellular stores Indications: * Mild to moderate chronic and acute pain Side effects/interactions: * Constipation * Nausea * Drowsiness * Avoid giving with sedatives
83
Strong opioid analgesics Drugs MoA Indications Side effects/interactions
* **Morphine** * **Diamorphine** * **Pethidine** * **Fentanil** Mimic endogenous opioids acting on opioid receptors µ, K, delta and ORL-1. Decrease neuronal transmission by: * Hyperpolarises the cell so it is less likely to fire when AP arrives: * Decreases opening of voltage gated Ca2+ channels * Increases K+ outflow via KATP and KIR channels * Reduces exocytosis of transmitter vesicles * Decreases Ca2+ release from intracellular stores Indications: * Severe pain * Cancer care, palliative care, coronary care Side effects/interactions: * Drowsiness * Respiratory depression * Constipation * Nausea * Tolerance and dependance/withdrawal * Avoid with sedatives
84
Partial/mixed opioid analgesics Drugs MoA Indications Side effects/interactions
* **Buprenorphine** * **Pentazocine** Modulation of analgesic opioid receptors (agonist for u and antagonist for k) Indications: * Moderate to severe pain * Opioid addiction Side effects/interactions: * Constipation * Nausea * Avoid with sedatives
85
Opioid antagonists Drugs MoA Indications Side effects/interactions
* **Naloxone (shorter half life)** * **Naltrexone (longer half life)** Competitive opioid receptor antagonist Indications: * Opioid overdose, respiratory depression Side effects/interactions: * Nausea * Constipation
86
Drugs for the management of opioid addiction MoA Indications Side effects/interactions
* **Buprenorphine** µ agonist and k antagonist * **Methadone** µ agonist, narcotic opioid replacement Indications: * Opioid addiction Side effects: * Constipation * Nausea * Avoid with sedatives
87
Drugs for neuropathic pain MoA Indications Side effects/interactions
* **Pregabalin** VDCC antagonist * **Gabapentin** VDCC antagonist * **Amitriptyline** See tricyclic antidepressants Indications: * Neuropathic pain Side effects/interactions: * Dizziness * Fatigue
88
Inhaled analgesics: Nitrous Oxide Drugs MoA Indications Side effects/interactions
* **Nitrous oxide** MoA unclear Indications: * Analgesia during childbirth Side effects/interactions: * Decreased vitamin B12 synthesis
89
General anaesthetics Drugs MoA Indications Side effects/interactions
* **Propofol (IV)**: MoA unclear * **Isoflurane (inhaled)**: MoA unclear * **Sevoflurane (inhaled)**: MoA unclear * **Ketamine (IV)** : NDMA receptor blockade Indications: * Induction of anaesthesia for major surgery * Propofol: maintenance of anaesthesia Side effects/interactions: * Decreased cardiac contractility * Respiratory depression (in overdose leading to respiratory failure and death) * Decreased CNS function * Reduced sympathetic activity
90
Local anaesthetics Drugs MoA Indications Side effects/interactions
* **Lidocaine** * **Bupivicaine** * **Levobupivaine** Voltage-gated sodium channel blockade in 2 ways: * Directly entering open sodium channels (use-dependence, more channels open = bigger the effect) * Accessing sodium channels by crossing axonal membrane and binding from the inside Indications: * Local anaesthesia: * Lidocaine: regional IV anaesthesia, nerve block, dental and topical. * Bupivicaine/levobupivicaine: local infiltration, regional IV anaesthesia, epidural, peripheral nerve block, sympathetic block. Side effects/interactions: * Rash
91
Non-depolarising neuromuscular blockers Drugs MoA Indications Side effects/interactions
* **Atracurium besolate** * **Vecuronium** Competitive antagonists of Ach receptors preventing depolarisation, blocking the effect of Ach. Also act presynaptically to reduce Ca2+ entry, reducing its release in vesicles into the synaptic cleft. 3-4 min time to max block, 40-45 min duration. Indications: * Tracheal intubation and mechanical ventilation during surgery Side effects/interactions: * No CNS side effects due to inability to cross BBB * Vecuronium has active metabolite that may produce residual paralysis * Hypotension * Skin flushing
92
Depolarising neuromuscular blockers Drugs MoA Indications Side effects/interactions
* **Neostigmine** ​Non-competitive block of acetylcholinesterase (AchE) breakdown of Ach to increase levels of Ach in the junctional cleft. Causes muscle paralysis by overloading the system, activating all Ach receptors at maximum and leaving no room for additional movement; similar to depolarising NMBs. * **Suxamethonium** Rapid action, muscle relaxation within 1 minute: needs continuous infusion. Non-competitive agonists of ACh receptors causing prolonged depolarisation (causes receptor to close and repolarise despite receptor still being bound) and blockage of the receptor preventing further depolarisation and muscle contraction. Indications: * Tracheal intubation and ventilation during surgery * Relaxes muscles by blocking ACh at the NMJ Side effects: * Initial depolarisation causes fasciculations and increased likelihood of pain on recovery * Increase parasympathetic activity: * Bradycardia * Increased secretion and peristalsis
93
Drugs for reversing neuromuscular block MoA Indications Side effects/interactions
* **Neostigmine** ​Anticholinesterase Reverses the effects of non-polarising NMB but prolongs the effects of polarising NMB suxamethonium. * **Sugammadex** ​Selective relaxant binding agent, binds to the drug to form a complex, encapsulating and inactivating it and preventing it from working at the NMJ. Rapid action, rapidly cleared from plasma and excreted in urine No effect on the cholinergic nervous system, minimises risk of residual paralysis. Indications: * Sugammadex: Immediate reversal of NMB to reduce post-operative pulmonary compications * Neostigmine: reversal of non-polarising NMB. Also used in myasthenia gravis. Side effects/interactions: * Neostigmine: bradycardia due to muscarinic effects on PNS.
94
Sedatives/muscle relaxants: **Dexmedetomidine** MoA Indications Side effects/interactions
By binding to the presynaptic α-2 adrenoceptors in the brain, dexmedetomidine inhibits the release of noradrenaline, and terminates the propagation of pain signals. Activation of the postsynaptic α-2 adrenoceptors inhibits the sympathetic activity, decreasing blood pressure and heart rate. Indications: * Used as a sedative in intensive care if the patient needs to maintain verbal responsiveness. * Maintain sedation and relaxed muscle tone Side effects/interactions: * Bradycardia
95
Muscle relaxants/sedatives: opioids Drugs MoA Indications Side effects/interactions
* **Fentanil** * **Alfentanil** * **Remifentanil** Opioid receptor agonists Indications: * Maintenance of sedation and relaxed muscle tone * Fentanil: used for severe pain Side effects/interactions: * Respiratory depression * Constipation
96
Anti-emetics: H1 receptor antagonists Drugs MoA Indications Side effects/interactions
* **Cyclizine** Histamine H1 receptor blockade Indications: * Nausea * Vomiting Side effects/interactions: * Dry mouth * Sedation * High as a kite if taken IV
97
Anti-emetics: D2 receptor antagonists Drugs MoA Indications Side effects/interactions
* **Domperidone** Dopamine D2 receptor blockade in the Chemoreceptor Trigger Zone. Indications: * Nausea and vomiting Side effects/interactions: * Cardiac disease
98
Beta Lactams: Penicillins Drugs MoA Indications Side effects/interactions
* **Benzylpenicillin** * **Amoxicillin**: LRTIs * **Coamoxiclav**: mixed infections e.g. dental abscesses and complicated LRTIs * **Penicillin**: tonsilitis * **Flucloxacillin**: SSTIs * **Piperacillin/tazobactam**: Complex LRTI Bacteriocidal, target bacterial cell wall- block cell wall synthesis causing cell lysis. Poor activity against intracellular organisms (e.g. legionella) or those with abnormal cell wall (e.g. chlamydia) Side effects/interactions: * Avoid use in patients with penicillin or cephalosporin induced anaphylaxis. * Rash/hypersensitivity * Interact with warfarin and methotrexate
99
Beta lactams: cephalosporins Drugs MoA Indications Side effects/interactions
* **Ceftriaxone** Bacteriocidal: cause cell lysis by blocking cell wall synthesis Indications: * Abdominal sepsis * Gram -ve infections * Bacterial meningitis * Orthopaedic infections Side effects/interactions: * Around 10% with penicillin allergy also have allergy to cephalosporins * Increased risk of CDAD * GI disturbances * Colitis * Interacts with warfarin
100
Beta lactams: carbapenems Drugs MoA Indications Side effects/interactions
* **Meropenem** Bacteriocidal- block cell wall synthesis causing cell lysis. Indications: * Complex and multi drug resistant UTIs * Infections in intensive care * Hospital acquired septicaemia Side effects/interactions: * Abdominal pain * Pruritis
101
Antifolate antibiotic Drug MoA Indications Side effects/interactions
* **Trimethoprim** Inhibition of dihydrofolate reductase. Bacteriostatic. Indications: * UTI (uncomplicated) Side effects/interactions: * Rash * GI disturbances * Interacts with methotrexate * Contraindicated in pregnancy
102
Fluoroquinolones Drugs MoA Indications Side effects/interactions
* **Ciprofloxacin** Bactericidal if high dose: Inhibition of bacterial DNA gyrase enzyme, targets DNA structure and function. Indications: * Respiratory tract infections * Gram -ve infections excluding anaerobes * MRSA Side effects/interactions: * Nausea * Convulsions * Interacts with iron salts, NSAIDs
103
Macrolide antibiotics Drugs MoA Indications Side effects/interactions
* **​Erythromycin** * **Azithromycin** Bacteriostatic: target RNA and inhibition of bacterial protein synthesis. Indications: * LRTI * URTI * SSTI (in place of penicillins) * Atypical LRTIs (intracellular organisms) Side effects/interactions: * GI disturbance * Headaches * Interacts with digoxin, theophylline, statins
104
Tetracycline antibiotic Drugs MoA Indications Side effects/interactions
* **Doxycycline** Bacteriostatic: target RNA and inhibit bacterial protein synthesis Indications: * Atypical bacteria that lack the normal cell wall: * Chlamydia * Mycoplasmia * Rickettsia * e.g Typhus * CAP Side effects/interactions: * Use limited by GI intolerance * Photosensitivity
105
Nitrofuran antibiotic Drug MoA Indications Side effects/interactions
* **Nitrofurantoin** Interferes with bacterial DNA synthesis- bactericidal if high dose Indications: * Uncomplicated UTI Side effects/interactions: * Peripheral neuropathy
106
Aminoglycosides Drugs MoA Indications Side effects/interactions
* **Gentamicin** Bactericidal if high dose: targets RNA, inhibition of bacterial protein synthesis Indications: * Severe gram -ve infections * Synergistic treatment for bacterial endocarditis * Opthalmic infection Side effects/interactions: * Use limited by renal toxicity and need for monitoring of drug levels
107
Glycopeptides Drugs MoA Indications Side effects/interactions
* **Vancomycin** Bactericidal: target bacterial cell wall in gram +ve bacteria Indications: * Multi drug resistant gram +ve cocci * E.g MRSA * C difficile infection Side effects/interactions: * Use limited by renal toxicity and need for monitoring of drug levels * Neutropenia * Renal impairment
108
Nitroimidazoles Drugs MoA Indications Side effects/interactions
* **Metronidazole** Bactericidal if high dose: inhibition of bacterial DNA synthesis Indications: * Anaerobic bacterial infections: * Leg ulcers * Pressure sores * Abscesses * Bacterial vaginosis Side effects/interactions: * Alcohol contraindicated
109
Antituberculosis drugs MoA Indications Side effects/interactions
* **Isoniazid** Inhibition of bacterial cell wall synthesis * **Ethambutol** Inhibition of bacterial cell wall synthesis * **Rifampicin** Inhibition of mycobacterial RNA synthesis * **Pyrazinamide** Indications: * Tuberculosis Side effects/interactions: * Hepatotoxicity
110
Therapeutic cytokines Drugs MoA Indications Side effects/interactions
* **Interferon alpha** Activation of antiviral intracellular and immune responses Indications: * Hepatitis B * Hepatitis C * Viral hepatitis from chronic CMB and EBV infections Side effects/interactions: * Flu-like symptoms * Loss of appetite * Fever * Lethargy * Depression * Secondary to night sweats -\> sleep deprivation
111
DNA polymerase inhibitors Drugs MoA Indications Side effects/interactions
* **Aciclovir** * **Ganciclovir** Virus replication blockade. Aciclovir is converted to is triphosphate form (aciclovir triphosphate- ACV-TP) which competitively inhibits viral DNA polymerase, incorporates into and terminates the growing viral DNA chain and inactivates the viral DNA polymerase. Indications: * Herpes simplex infection Side effects/interactions: * Nausea * Diarrhoea
112
Neuraminidase inhibitors Drugs MoA Indications Side effects/interactions
* **Oseltamivir** Prevention of viral budding and infectivity Indications: * Influenza Side effects/interactions: * Nausea and vomiting
113
Nucleoside analogues Drugs MoA Indications
* **Ribavirin** Disrupts viral RNA synthesis Indications: * Hepatitis C * RSV
114
Nucleoside reverse transcriptase inhibitors Drugs MoA Indications Side effects/interactions
* **Tenofovir** Blockade of viral reverse transcriptase function for viral replication Indications: * HIV infection Side effects/interactions: * Rash * Steven-Johnson syndrome
115
Non-nucleoside reverse transcriptase inhibitors (NNRTI) Drugs MoA Indications Side effects/interactions
* **Efavirenz** Blockade of viral reverse transcriptase function for viral genetic replication Indications: * HIV infection Side effects: * Rash * Steven-Johnson syndrome
116
Viral protease inhibitors Drugs MoA Indications Side effects/interactions
* **Lopinavir** Blockade of viral protease required for virus particle assembly Indications: * HIV infection Side effects/interactions: * GI bleeding
117
Integrase inhibitors Drugs MoA Indications Side effects/interactions
* **Dolutegravir** Disrupts integration of HIV genome into host chromosomes Indications: * HIV
118
Viral fusion inhibitors Drugs MoA Indications Side effects
* **Enfuvirtide** Blockade of virus fusion to target cell membrane Indications: * HIV Side effects/interactions: * Pancreatitis
119
Chemokine receptor/CC5 antagonists Drugs MoA Indications Side effects
* **Maraviroc** Blockade of HIV binding to co- factor for cell entry Indications: * HIV Side effects/interactions: * Nausea * Diarrhoea
120
Triazole anti-fungal agent Drug MoA Indication Side effects/interactions
* **Fluconazole** Disruption of fungal membrane function Indication: * Candida infection Side effects: * Nausea * Abdominal pain
121
Insulin MoA Indication Side effects/interactions
Increases uptake of glucose by cells Indications: * T1 & T2DM Side effects/interactions: * Hypoglycaemia * Interacts with digoxin, beta blockers
122
Oral biguinade Drug MoA Indications Side effects/interactions
* **Metformin** Increases insulin sensitivity & inhibits hepatic gluconeogenesis Indications: * T2DM Side effects: * Nausea and vomiting * Interacts with digoxin, diuretics
123
Sulphonyureas Drugs MoA Indications Side effects/interactions
* **Gliclizide** Stimulates pancreatic insulin secretion Indications: * T2DM Side effects/interactions: * Hypoglycaemia * Interacts with warfarin, NSAIDs
124
Thiazolidinediones Drugs MoA Indications Side effects/interactions
* **Pioglitazone** Increases insulin sensitivity in muscle and adipose tissue Indications: * T2DM Side effects/interactions: * Weight gain
125
Glucagon-like peptide-1 receptor (GLP-1) agonist Drugs MoA Indications Side effects/interactions
* **Exenatide** Incretin analogue- improves glucose control Indications: * T2DM Side effects/interactions: * Asthenia
126
Dipeptidyl peptidase-4 (DPP-4) Inhibitor Drugs MoA Indications Side effects/interactions
* **Sitaliptin** Reduces inactivation of incretins Indications: * T2DM Side effects/interactions: * Headache
127
Lipase inhibitors Drugs MoA Indications Side effects/interactions
* **Orlistat** Inhibition of GI uptake of dietary fat Indications: * Obesity, especially in the presence of T2DM Side effects: * Steatorrhoea * Faecal urgency
128
Thyroid hormones Drugs MoA Indications Side effects/interactions
* **Levothyroxine sodium (T4)** * **Liothyronine sodium (T3)** Synthetic hormones to replace deficiency Indications: * Hypothyroidism Side effects/interactions: * Diarrhoea * Vomiting * Interacts with oral anticoagulants
129
Disease modifying anti-rheumatic drugs: antifolate antiproliferatives Drugs MoA Indications Side effects/interactions
* **Methotrexate** Inhibition of dihydrofolate reductase and DNA synthesis for lymphocyte proliferation Indications: * Rheumatoid arthritis * Broad spectrum of malignancies Side effects/interactions: * Nausea * Hair loss * Interacts with warfarin and corticosteroids
130
DMARDS: antimetabolite immunosuppressant Drug MoA Indications Side effects/interactions
* **Azathioprine** MoA unclear Indications: * Rheumatoid arthritis * Crohn's disease Side effects: * Alopecia
131
DMARDS: cytokine modulators Drugs MoA Indications Side effects/interactions
* **Adalimumab** * **Infliximab** * **Etanercept** Blockade of TNF-alpha Indications: * Rheumatoid arthritis Side effects/interactions: * Infections
132
DMARDS: aminosalicylates Drugs MoA Indications Side effects/interactions
* **Sulfasalazine** * **Mesalazine** MoA unclear: possible COX inhibition; possible free radical scavenging, T cell suppression. Indications: * Rheumatoid arthritis * Crohn's disease Side effects/interactions: * Nausea * Interacts with digoxin, warfarin
133
Combined oral contraceptive pill Drug MoA Indications Side effects/interactions
* **Desogestrel and ethinyl-estradiol** Mimics ovulation, minimises LH and FSH. Indications: * Contraception * Polycystic ovary syndrome (PCOS) Side effects/interactions: * Weight gain * Depression * Increased DVT risk
134
Oral mini-contraceptive pill: progesterone only MoA Indications Side effects/interactions
* **Desogestrel** * **Levonorgestrel** (emergency contraception) Mimics ovulation, decreases LH and FSH, endometrial changes. Indication: * Hormonal contraception Side effects/interactions: * Depression
135
Implants/injectable contraception Drugs MoA Indications Side effects/interactions
* **Etonogestrel** (subcutaneous implant) Mimics ovulation, decreases LH and FSH Indications: * Hormonal contraception Side effects: * Weight gain * Depression
136
Hormone replacement therapy Drugs MoA Indications Side effects/interactions
* **Estradiol** * **Norethisterone** * **Medroxyprogesterone** Restores decreased hormone level and function Indications: * Menopause Side effects/interactions: * Weight gain * Depression
137
Dinoprostone MoA Indications
* **Dinoprostone** Prostaglandin E2: stimulates cervical ripening Indications: * Delay in labour
138
Augmentation of labour drugs MoA Indications Side effects/interactions
* **Oxytocin** Stimulates uterine contractions Indications: * Delayed labour Side effects/interactions: * Nausea * Arrhythmias
139
Antiprogestogen/prostaglandin for medical termination Drug MoA Side effects/interactions
* **Misoprostol with mifepristone** Steroidal antiprogestogen in combination with synthetic prostadlandin Indication: * Medical termination of pregnancy Side effects: * GI cramps * Uterine contractions * Vaginal bleeding
140
Antifibrinolytic for menorrhagia MoA Side effects/interactions
* **Tranexamic acid** Inhibits fibrin clot breakdown by fibrin Indication: menorrhagia Side effects/interactions: * Nausea
141
NSAID for dysmenorrhoea MoA Side effects/interactions
* **Mefenamic acid** Inhibition of prostaglandin synthesis Indications: dysmenorrhoea Side effects/interactions: * GI bleeding
142
Alpha-1 blocker Drug MoA Indications Side effects/interactions
* **Tamsulosin** Smooth muscle relaxant acting on Alpha-1a adrenoceptors in the prostate and and alpha-1d adrenoceptors in the detrusor muscle. Indications: * BPH * Urinary retention Side effects/interactions: * Dizziness * Avoid with hypotensive drugs
143
Urinary antispasmodic (antimuscarinic) Drug MoA Indications Side effects/interactions
* **Oxybutynin** Blockade of acetylcholine receptors leading to relaxation of smooth muscle in the bladder neck. Indications: * Overactive bladder Side effects/interactions: * Dry mouth * Tachy cardia preceded by transient bradycardia
144
Beta-3 agonist Drug MoA Indications Side effects/interactions
* **Mirabegron** Stimulatin of Beta-3 adrenergic receptors, leading to relaxation of detrusor smooth muscle. Indications: * Overactive bladder Side effects/interactions: * Bladder pain
145
Anti-adrogen Drug MoA Indications Side effects/interactions
* **Finasteride** Inhibition of synthesis of dihydrotestosterone Indications: * BPH Side effects/interactions: * Impotence
146
Anti-histamines Drugs MoA Indications Side effects/interactions
* **Chloramphenamine** H1 histamine receptor blockade Indications: * Hay fever * Urticaria Side effects/interactions: * Dry mouth * Sedation * Interacts with TCAs
147
Glucocorticoids Drugs MoA Indications Side effects/interactions
* **Prednisolone** * **Hydrocortisone** * **Dexamethasone** Intracellular transcription factor interactions, gene expression Indications: * Suppression of inflammatory diseases: * Crohn's * RA Side effects/interactions: * Weight gain * Muscle atrophy * Interacts with oral antidiabetics
148
Calcineurin inhibitors Drugs MoA Indications Side effects/interactions
* **Cyclosporin** * **Tacrolimus** Inhibition of T cell signalling Indications: * Solid organ transplantation * Eczema (topical form) Side effects/interactions: * Hypertension * Interacts with aspirin
149
Antineoplastic drugs: classical alkylating agents Drugs MoA Indications Side effects/interactions
* **Cyclophosphamide** DNA crosslinking Indications: * Broad spectrum of malignancies Side effects/interactions: * Hair loss * Nausea * Bone marrow suppression
150
Antineoplastic drugs: taxanes Drugs MoA Indications Side effects/interactions
* **Paclitaxel** * **Docetaxel** Inhibition of microtubule assembly in the mitotic spindle Indication: * Broad spectrum of malignancies Side effects/interactions: * Hair loss * Nausea * Bone marrow suppression
151
Anti-neoplastic drugs: Vinca Alkaloids Drugs MoA Indications Side effects/interactions
* **Vincristine** * **Vinblastine** Inhibition of microtubule assembly in mitotic spindle Indications: * Broad spectrum of malignancies Side effects/interactions: * Hair loss * Nausea * Bone marrow suppression
152
Anti-neoplastic drugs: Antipyramidines Drugs MoA Indications Side effects/interactions
* **Fluorouracil** * **Cytarabine** Inhibition of RNA and DNA synthesis Indications: * Broad spectrum of malignancies Side effects/interactions: * Hair loss * Bone marrow suppression * Nausea
153
Anti-neoplastic drugs: Antipurines Drugs MoA Indications Side effects/interactions
* **Mercaptopurine** * **Thioguanine** Inhibition of DNA and RNA synthesis Indications: * Broad spectrum of malignancies Side effects/interactions: * Hair loss * Nausea * Bone marrow suppression
154
Anti-neoplastic drugs: Anthracycline antibiotics Drugs MoA Indications Side effects/interactions
* **Doxorubicin** DNA intercalation; Inhibition of RNA and DNA synthesis Indications: * Broad spectrum of malignancies Side effects: * Hair loss * Bone marrow suppression * Nausea
155
Antineoplastic monoclonal antibodies: Trastuzumab Drugs MoA Indications Side effects/interactions
* **Trastuzumab** Targets cells that overexpress Human Epidermal Growth Factor Receptor-2 (HER2) for tumour reduction and destruction. Indications: * Early breast cancer Side effects/interactions: * Fever * Chills
156
Antineoplastic monoclonal antibodies: Rituximab MoA Indications Side effects/interactions
* **Rituximab** Targeted destruction of CD20+ B cells Indications: * Follicular lymphoma * Non-Hodgkins lymphoma Side effects/interactions: * Fever * Chills
157
Antineoplastic monoclonal antibodies: Nivolumab MoA Indications Side effects/interactions
* **Nivolumab** Stimulation of anti-tumour responses via blocking PD-1 Indications: * Melanoma Side effects/interactions: * Fever * Chills
158
Antineoplastic drugs: immunomodulators Drugs MoA Indications Side effects/interactions
* **Lenolidamide** Stimulation of T cell responses Indications: * Myeloma Side effects/interactions: * Foetal risk
159
Anti-neoplastic drugs: Selective oestrogen receptor modulation (SERM) Drugs MoA Indications
* **Tamoxifen** Inhibition of oestrogen receptor function and cell proliferation in the breast Indications: * Breast cancer
160
Antineoplastic drugs: Luteinising hormone releasing hormone (LHRH) receptor agonist Drug MoA Indications
* **Goserelin** Synthetic analogue of LHRH. Activates LHRH receptor function leading to sustained reduction in testosterone Indications: * Prostate cancer
161
Drugs for treatment of bone and calcium homeostasis: therapeutic hormones Drugs MoA Indications Side effects/interactions
* **Calcitonin** Inhibits mobilisation of calcium from bones Indications: * Osteoporosis * Hypercalcaemia Side effects/interactions: * Abdominal pain * Interacts with antacids
162
Bisphosphonates Drugs MoA Indications
* **Alendronate** * **Pamidronate** Inhibits osteoclast function and bone resorption Indications: * Osteoporosis * Hypercalcaemia
163
Drugs for hypocalcaemia MoA Indications
* **IV calcium gluconate** * **Parathyroid hormone** * **Vitamin D** Restoration of calcium levels and metabolism Indications: * Hypocalcaemia * Bone loss
164
Drugs for vitamin D deficiency MoA Indications Side effects/interactions
* Vitamin D * **Colecalciferol** * **Calcitriol** * **1,25-dihydroxy vitamin D** (usually only in the cases of advanced CKD) Restoration of vitamin D levels Indications: * Vitamin D deficiency
165
Selective oestrogen receptor modulator for osteoporosis Drug MoA Indications Side effects/interactions
* **Raloxifene** Stimulation of oestrogen function in bone Indications: * Osteoporosis * Prevention of bone fractures Side effects/interactions: * Hot flushes * Interacts with warfarin
166
Drugs for treatment of calcium and bone homeostasis: monoclonal antibody MoA Indication Side effects/interactions
* **Denosumab** Inhibition of osteoclast function and bone resorption Indications: * Osteoporosis Side effects/interactions: * Hypocalcaemia
167
Ferrous sulphate Class MoA Indications Side effects/interactions
**Ferrous sulphate** Class: Oral iron compound Iron provision Indications: * Iron deficiency anaemia Side effects/interactions: * Constipation * Interacts with antacids (reduced absorption)
168
Folic acid Class MoA Indications
**Folic acid** Water soluble vitamin Supports nucleic acid synthesis Indications: * Folate-deficient anaemia
169
Parenteral Vitamin B12 MoA Indications
Watersoluble vitamin, enzyme cofactor Indications: * Pernicious anaemia
170
Calcium channel blockers: Verapamil MoA Indications Side effects
Mostly works on cardiac muscle. Slows Ca entry during phases 2 and 3 of cardiac action potential. * Moderate reduction in SVR by peripheral vasodilation * Moderate coronary vasodilation * Moderate decrease in cardiac contractility * Large reduction in heart rate * Mild reduction in stroke volume (Mild decrease in BP) Indications: HTN, tachyarrhythmias (esp re-entry and atrial origin) Side effects: * Heart failure * Heart block (esp when used with a B blocker) * Peripheral oedema * Constipation * Facial flushing * Headaches
171
Calcium channel blockers: Diltiazem MoA Indications Side effects
Affects cardiac smooth muscle * Mild reduction in SVR through peripheral vasodilation * Moderate coronary vasodilation (useful for angina) * Moderate slowing of AV node- antiarrhythmic * Mild reduction in HR and stroke volume Mild decrease in BP Indications: HTN, arrhythmia, angina Side effects: * Facial flushing * Headaches * Peripheral oedema * Heart failure * Heart block
172
Calcium channel blockers: dihydropyridines Drugs MoA Indications Side effects
Amlodipine and Nifedipine * Large reduction in SVR by peripheral vasodilation * Moderat cardiac vasodilation * Mild decreased cardiac contractility * Moderate reflex increase in sympathetic tone * Mild slowing of AV node conduction * High increase in HR (compensatory from drop in BP) * Moderate natriuresis and diuresis Indications: HTN Side effects: * Marked facial flushing * Headaches * Peripheral oedema * Polyuria (exacerbate prostatism)